Lipscomb University
Print this page Email this page
Left to Right: Jeff McCormack, Bo Bartholomew, Jon Perlin, Dick Cowart, Dee Anna Smith, Bill Hix, Joey Jacobs, Roger Davis

 

Samuel W. Bartholomew, III
President and Chief Executive Officer, Pharm MD

 As President, CEO and a founder of Pharm MD, Mr. Bartholomew has led the development of Pharm MD's services and products with a team of clinical and IT experts from around the country.  Prior to helping form Pharm MD, Mr. Bartholomew served as Vice President of Business Development for Integration Management, Inc.  He also served as managing partner of Integration Ventures, LLC, a joint venture partner of Integration Management that worked to leverage healthcare data expertise and technology to improve employer healthcare costs and managed care company profitability.  Mr. Bartholomew has also served as Associate Administrator for Centennial Medical Center in Nashville, Tennessee, as well as Stone Crest Medical Center in Smyrna, Tennessee.

 

David L. Black, Ph.D., D-ABFT, FAIC
President and Chief Executive Officer, Aegis Sciences Corporation

Dr. David L. Black is an internationally recognized forensic toxicologist and founder of Aegis®.  Currently, Dr. Black serves as a consultant to major organizations for development of substance abuse prevention and testing programs.  Dr. Black has extensive experience as an expert witness in local, state, national and international court cases involving drug use and testing. He earned his undergraduate degree from Loyola College in Baltimore and doctorate degree in forensic toxicology from the University of Maryland at Baltimore.  Dr. Black is a diplomat of the American Board of Forensic Toxicology (D-ABFT) and a Fellow of the American Institute of Chemists (FAIC).  Dr. Black is currently a Clinical Associate Professor with an appointment in Pathology at Vanderbilt University.

Janet S. Calhoun
Senior Vice President, Medco & Healthways New Product Development Collaborative

Ms. Calhoun serves as Senior Vice President for Healthways and is the Executive Director for the Healthways/Medco New Product Development Collaborative.  In her role, Ms. Calhoun is leading the strategic planning efforts around a variety of next generation solutions that will leverage and integrate pharmacy therapy management, health, wellness, and condition management services.  Under her leadership, the joint Healthways/Medco offering is focusing on addressing a number of critical pharmacy therapy issues, such as adherence and patient education.  Ms. Calhoun is also leading the development of solutions and programs that will enhance a clinician's ability to incorporate information from a variety of sources (medical, pharmacy, lab, etc.) to facilitate accelerated, informed, and comprehensive engagement with an individual. 

 

Dick Cowart
Attorney at Law, Baker, Donelson, Bearman, Caldwell, & Berkowitz

Mr. Cowart is the Chairman of the Health Law Department and Public Policy Department of Baker, Donelson, Bearman, Caldwell & Berkowitz, and is the past President of the American Healthy Lawyers Association.  Mr. Cowart is a recognized authority in advising clients on the legal, regulatory and business issues related to health care services.  He works primarily as board counsel to health service organizations (both for profit and not-for-profit) and counsels providers on business, policy and governance issues, with an emphasis on business transactions.  Mr. Cowart is a nationally known speaker and writer on health care issues.  He was the national columnist for Medical News, Inc. for 16 years and is the health business columnist for The Tennessean.

 

J. William Hix, Board of Visitor Emeritus

Mr. Hix is responsible for all sales and marketing efforts at Cumberland Pharmaceuticals.  He joined the company in 2004 to form and manage the national sales force promoting the acute care product line to hospitals, poison control centers and physicians.  He was also instrumental in the design and implementation of Cumberland's field sales force which is responsible for promoting Cumberland products in the gastroenterology market.  Mr. Hix brings significant industry experience to Cumberland, having spent thirty years at Novartis/CIBA-GEIGY Pharmaceutical Corporation.  There his responsibilities ranged from sales operations, planning and promotion to marketing support and regulatory compliance.

 

Joey A. Jacobs
Chairman, President and Chief Executive Officer, Psychiatric Solutions, Inc.

Mr. Jacobs co-founded Psychiatric Solutions, Inc and has served as Chairman, President and Chief Executive Officer since April 1997.  Prior to founding PSI, Mr. Jacobs served for 21 years in various capacities with Hospital Corporation of America (HCA), most recently as President of the Tennessee Division.  Mr. Jacobs' background at HCA also includes serving as President of HCA's Central Group, Vice President of the Western Group, Assistant Vice President of the Central Group and Assistant Vice President of the Salt Lake City Division.

 

Paul Keckley, Ph.D.
Executive Director, Deloitte Center for Health Solutions

Dr. Keckley is the executive director of the Deloitte Center for Health Solutions, a part of Deloitte & Touche USA, LLP.  He provides strategic guidance on the development of Center research and thought leadership.  Dr. Keckley has had 30 years of experience in academic medicine and the private sector.  Prior to joining Deloitte, Dr. Keckley served in several key roles at Vanderbilt University in Nashville, Tennessee.  These roles include being the Executive Director of the Vanderbilt Center for Evidence-based Medicine, Associate Professor at Vanderbilt University School of Medicine, and as an Associate Professor of Health Management at the Owen Graduate School of Business.  He is well regarded for his knowledge of healthcare economics, health policy, and trend analysis. 

 

Jim Monsor
Senior Vice President of Operations, BioMimetic Therapeutics
 
Mr. Monsor is Senior Vice President of Operations for BioMimetic Therapeutics. In that capacity he is responsible for the entire product supply chain, contract manufacturing, quality control, IT, and the Life Sciences Center Construction Project. He is the fourth employee and has seen BMTI develop to nearly a 100 person operation. Mr. Monsor spent fifteen years at Abbott Laboratories, and more recently was Director of Product Supply for ALK-Abello, where he was responsible for the entire product supply chain for US operations. He has broad experience in supply chain management, quality, regulatory, IT, and facilities management for drug, device and bulk drug products.

 

Don Nickelson, CPA
Chief Executive Officer and President, Comphrehensive Pharmacy Services, Inc.

At Comprehensive Pharmacy Services, Mr. Nickelson's responsibilities include establishing strategic direction and corporate leadership as well as serving on the Board of Directors for CPS.  He has over 25 years of organizational leadership experience.  Mr. Nickelson was a former Regional President for US Office Products and has held key positions with Mills Morris Arrow, Inc. Mr. Nickelson is a member of the American Institute of Certifies Public Accountants, as well as the Tennessee Society of Certified Public Accountants.

 

Jonathan B. Perlin, MD, Ph.D., MSHA, FACP
Chief Medical Officer and President, Clinical Services, Hospital Corporation of America (HCA)

Dr. Perlin is President, Clinical Services and Chief Medical Officer of Nashville, Tennessee- based Hospital Corporation of America.  He provides leadership for clinical services and improving performance at HCA's 163 hospitals and 112 outpatient centers.  His current activities include implementing electronic health records throughout HCA, improving clinical "core measures" to benchmark levels, and leading patient safety programs to eliminate preventable, drug resistant, healthcare-associated infections.  Before joining HCA in 2006, Dr. Perlin was Under Secretary for Health in the U.S. Department of Veterans Affairs.  Dr. Perlin has served on numerous Boards and Commissions including the National Quality Forum, the Joint Commission, Meharry Medical College and the American Health Information Community.  Dr. Perlin is also broadly published in healthcare quality and transformation.  He is also a Fellow of the American College of Physicians and the American College of Medical Informatics.

 

Dee Anna Smith, CPA
Chief Executive Officer, Sarah Cannon Research Institute (SCRI)

Ms. Smith is the Chief Executive Officer of Sarah Cannon Research Institute (SCRI), one of the nation's largest clinical research programs.  With over a decade of experience in clinical research, Ms. Smith is responsible for carrying out the overall strategic mission and vision for SCRI.  She has also had the role of Chief Information Officer and President of SCRI.  Prior to her work with Sarah Cannon Research Institute, Ms. Smith served as Chief Executive Officer of Summit Research Solutions, a multi-specialty site management organization that she co-founded.  She has also served as the Chief Executive Officer of SiteWorks Solutions, another company she founded, providing customized, web-based site management systems for the clinical trials industry. 

 

Papatya Tankut, R.Ph.
Vice President, Professional Pharmacy Services, CVS/Caremark

Ms. Tankut currently serves as the Vice President of Professional Pharmacy Services for CVS/Caremark.  In this role, her major responsibilities include developing the company's Pharmacist recruitment strategies and initiatives, overseeing the regulatory compliance, quality assurance, clinical services and patient care programs departments.  Ms. Tankut has held various positions with CVS including Manager of Professional and College Relations, Director of Pharmacy Recruiting and Professional Relations, and Community Pharmacist. 

 

Barbara Cannon Wall
CEO, Alive Hospice

In hot growth industries like Biotech and Medical Devices, executives must have a firm grasp of their market, knowing when to take a company public and when to remain private.  Barbara Cannon Wall, an 18-year bio-tech veteran, has experienced first-hand the challenges that arise running a publicly traded company.  Wall has held senior management positions with a number of healthcare services companies on both the public and private side. She was formerly President and CEO of Celeris, a provider of specialty clinical research services. Prior to taking the helm at Celeris, Wall was President and CEO of  Summit Medical Systems (NASDAQ:SUMT).  Previously, Wall was Executive Vice President and COO of ClinTrials Research, which went public in 1993.  She has also held executive positions with the Institute of Clinical Pharmacology in Dublin, Ireland and American Hospital Supply Corporation. Education: BS, California State University, Sacramento; MBA, Kellogg School of Management, Northwestern University.